Equities analysts expect Procter & Gamble Co (NYSE:PG) to announce earnings of $1.10 per share for the current quarter, Zacks reports. Eight analysts have provided estimates for Procter & Gamble’s earnings. The highest EPS estimate is $1.13 and the lowest is $1.06. Procter & Gamble posted earnings of $1.09 per share in the same quarter last year, which indicates a positive year-over-year growth rate of 0.9%. The business is scheduled to announce its next quarterly earnings report on Friday, October 19th.
On average, analysts expect that Procter & Gamble will report full-year earnings of $4.42 per share for the current fiscal year, with EPS estimates ranging from $4.36 to $4.45. For the next fiscal year, analysts forecast that the business will report earnings of $4.69 per share, with EPS estimates ranging from $4.59 to $4.81. Zacks’ earnings per share calculations are a mean average based on a survey of research analysts that cover Procter & Gamble.
Procter & Gamble (NYSE:PG) last announced its quarterly earnings results on Tuesday, July 31st. The company reported $0.94 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.90 by $0.04. Procter & Gamble had a return on equity of 20.94% and a net margin of 14.59%. The company had revenue of $16.50 billion during the quarter, compared to analyst estimates of $16.52 billion. During the same quarter in the previous year, the firm posted $0.85 EPS. The firm’s quarterly revenue was up 2.6% on a year-over-year basis.
A number of research analysts have issued reports on PG shares. UBS Group lowered Procter & Gamble from a “buy” rating to a “neutral” rating and set a $83.00 price target for the company. in a research report on Wednesday, July 18th. Morgan Stanley reiterated a “hold” rating on shares of Procter & Gamble in a research report on Monday, June 11th. ValuEngine lowered Procter & Gamble from a “hold” rating to a “sell” rating in a research report on Wednesday, May 2nd. Barclays reiterated a “hold” rating and set a $80.00 price target on shares of Procter & Gamble in a research report on Sunday, April 22nd. Finally, Jefferies Financial Group lowered Procter & Gamble from a “buy” rating to a “hold” rating and set a $95.00 price target for the company. in a research report on Monday, July 9th. One equities research analyst has rated the stock with a sell rating, fourteen have assigned a hold rating, four have issued a buy rating and one has given a strong buy rating to the company’s stock. The company currently has a consensus rating of “Hold” and an average price target of $84.79.
PG stock remained flat at $$83.69 during trading on Tuesday. The company’s stock had a trading volume of 8,335,388 shares, compared to its average volume of 9,298,539. The company has a quick ratio of 0.66, a current ratio of 0.83 and a debt-to-equity ratio of 0.40. Procter & Gamble has a one year low of $70.73 and a one year high of $94.67. The firm has a market cap of $205.29 billion, a price-to-earnings ratio of 19.83, a PEG ratio of 2.62 and a beta of 0.58.
The company also recently disclosed a quarterly dividend, which was paid on Wednesday, August 15th. Stockholders of record on Friday, July 20th were issued a $0.7172 dividend. The ex-dividend date was Thursday, July 19th. This represents a $2.87 annualized dividend and a dividend yield of 3.43%. Procter & Gamble’s dividend payout ratio (DPR) is 68.01%.
In other news, insider Gary A. Coombe sold 1,529 shares of the company’s stock in a transaction on Monday, June 4th. The stock was sold at an average price of $74.25, for a total value of $113,528.25. Following the completion of the sale, the insider now owns 5,235 shares in the company, valued at $388,698.75. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, insider Deborah P. Majoras sold 1,980 shares of the company’s stock in a transaction on Monday, August 13th. The shares were sold at an average price of $81.35, for a total value of $161,073.00. Following the completion of the sale, the insider now owns 50,074 shares of the company’s stock, valued at approximately $4,073,519.90. The disclosure for this sale can be found here. In the last 90 days, insiders sold 101,968 shares of company stock valued at $8,189,479. Insiders own 0.35% of the company’s stock.
Several institutional investors have recently made changes to their positions in the company. Phocas Financial Corp. raised its position in shares of Procter & Gamble by 99,943.2% during the second quarter. Phocas Financial Corp. now owns 7,573,274 shares of the company’s stock worth $591,000 after purchasing an additional 7,565,704 shares during the period. American International Group Inc. raised its position in shares of Procter & Gamble by 448.0% during the fourth quarter. American International Group Inc. now owns 6,567,310 shares of the company’s stock worth $603,404,000 after purchasing an additional 5,368,843 shares during the period. Franklin Resources Inc. raised its position in shares of Procter & Gamble by 63.1% during the first quarter. Franklin Resources Inc. now owns 11,150,063 shares of the company’s stock worth $883,964,000 after purchasing an additional 4,315,180 shares during the period. BlackRock Inc. raised its position in shares of Procter & Gamble by 2.2% during the second quarter. BlackRock Inc. now owns 166,150,277 shares of the company’s stock worth $12,969,690,000 after purchasing an additional 3,551,051 shares during the period. Finally, Charles Schwab Investment Advisory Inc. acquired a new stake in shares of Procter & Gamble during the second quarter worth $241,094,000. Institutional investors and hedge funds own 59.54% of the company’s stock.
Procter & Gamble Company Profile
The Procter & Gamble Company provides branded consumer packaged goods to consumers in the United States, Canada, Puerto Rico, Europe, the Asia Pacific, Greater China, Latin America, India, the Middle East, and Africa. The company's Beauty segment offers hair care products, including conditioners, shampoos, styling aids, and treatments; and skin and personal care products, such as antiperspirant and deodorant, personal cleansing, and skin care products.
Further Reading: Understanding Analyst Recommendations
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.